Uso clínico de canabidiol em patologias neurológicas: uma revisão narrativa
Loading...
Date
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Universidade Federal de Juiz de Fora - Campus Avançado de Governador Valadares
DOI
Abstract
In recent decades, there has been increasing interest in the therapeutic potential of Cannabis
derivatives for neurological disorders, with a strong stimulus for research in several areas, such
as refractory epilepsy and symptoms of multiple sclerosis (MS). The present study aims to
perform a narrative review regarding the therapeutic use of cannabidiol (CBD) derivatives for
alternative use in the treatment of neurological conditions, especially in epilepsy and MS. As
a result, 46 articles that met the inclusion criteria were selected. The results of this study showed
that most patients with refractory epilepsy who used CBD as monotherapy or complementary
treatment showed total or partial improvement. It was also possible to observe through this
study the evidence of the use of CBD to provide a clinically relevant improvement of resistant
spasticity in MS compared to first-line antispasticity drugs alone. However, the use of CBD is
limited for certain groups, including lactating women, the elderly, and pregnant women, due to
the lack of safety and efficacy data for them. Therefore, this study represents a contribution to
a better understanding of the potential therapeutic use of cannabidiol in the treatment of epilepsy
and MS.
Description
Keywords
Citation
Collections
Endorsement
Review
Supplemented By
Referenced By
Creative Commons license
Except where otherwise noted, this item's license is described as Acesso Aberto

